secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elanco Animal Health Inc (ELAN)
CIK:        0001739104
Form:       8-K
Filed at:   2025-05-28T23:59:59+00:00
Accession:  0001104659-25-053305
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elanco appoints Robert VanHimbergen as CFO effective July 7, 2025
-----------------------------------------------------------------

- Robert VanHimbergen appointed EVP and CFO, effective July 7, 2025; Todd Young stays as advisor through Aug 31, 2025.
- VanHimbergen previously SVP and CFO of Hillenbrand; prior 15 years at Johnson Controls and PwC.
- Base salary $660k, target annual cash incentive 75% of base, annual long-term incentive target $2.645M.
- Make-whole awards: cash bonus $890k (3-year clawback) and RSU $1.735M (3-year ratable vesting).
- Company reaffirmed Q2 and FY 2025 guidance issued May 7, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739104/000110465925053305/0001104659-25-053305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739104/000110465925053305/tm2516292d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-053305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer